FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Dimercaptosuccinic Acid Dmsa Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Technetium Tc 99m DMSA by intravenous administration is indicated as a static kidney imaging agent.
History
There is currently no drug history available for this drug.
Other Information
AnazaoHealth supplies DMSA as a compounded kit for preparing Tc 99m DMSA. Each Reaction vial contains 1.1 mg meso-2, 3-dimercaptosuccinic acid, 0.2 mg tin as stannous chloride, and 0.7 mg ascorbic acid. The vial is back filled with inert gas and may contain a partial vacuum.
Each Acetate buffer vial contains 1.2 ml Sodium Acetate .25 N. pH 5.2 to 5.6.
LDO normal saline included for dilution of prepared kit, if required
Sources
Dimercaptosuccinic Acid Dmsa Manufacturers
-
Anazaohealth Corporation
Dimercaptosuccinic Acid Dmsa | Anazaohealth Corporation
Preparation of Technetium Tc 99m DMSA is done by the following aseptic procedure:
Waterproof gloves should be worn during the preparation Snap off the plastic lid and place room temperature reaction vial in an appropriate lead shield. Swab the rubber closure of the vial with a germicide Inject as close to 1 cc as possible of sterile additive free sodium pertechnetate Tc 99m injection containing up to 1480 MBq (40 mCi) into the vial freshly eluded within 2 hours from a technetium generator. Be sure to maintain inert atmosphere in vial by introducing as little air as possible during reconstitution. NOTE: If sodium pertechnetate Tc 99m injection must be diluted, use only Low Dissolved Oxygen (LDO) Secure the lead shield cover. Swirl the vial gently to mix contents and let stand for 15 minutes. Add 1 ml Acetate buffer at this time. (This will interfere with the tagging process if introduced any earlier). Buffer must be added (May be added up to 1 hour after Tc 99m) Examine vial contents; if the solution is not clear and free of particulate matter and discoloration on visual inspection, it should not be used Measure the radioactivity by a suitable calibration system and record prior to patient administration Buffered material should be used within 2 hours Appropriate quality control is recommendedTagging Tips
If you need only a one or two mCi dose for your patient, use about 10 mCi of Tc 99m for your kit. Do not stretch your kit to 40 mCi if you do not need to. We have tested the kits to 40 mCi with a Friday generator eluted on Monday but recommend using only what you need Keep your volumes low. Take your Tc 99m and dilute to about 1cc with the Low Dissolved Oxygen saline and inject into the DMSA kit Let the kit stand for about 15 minutes with just the Tc 99m and DMSA (NO BUFFER) After 15 minutes, then add the buffer. This is only for patient comfort and will interfere with the tagging process if introduced any earlier After buffering you can add additional “Low Dissolved Oxygen” saline to dilute the kit You should inject the dose within 2 hours after making the kit for best results Storage and HandlingStore the kit at 2°-8°C (36°-46°F) and protect from light
Login To Your Free Account